Amgen reaps Horizon buyout rewards in Q3 as it gears up for key biosim launches

The California-based drugmaker pulled in $8.5 billion in revenue during the third quarter, a 23% increase compared with the same period in 2023. Taking out sales derived from the Horizon acquisition, however, puts the company's growth rate at 8%.